Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT
详细信息 查看全文
- 作者：Ken Ishiyamaa ; ishiyama-knz@umin.ac.jp" class="auth_mail" title="E-mail the corresponding author ; Takuhiro Yamaguchib ; Tetsuya Etoc ; Kazuteru Ohashid ; Naoyuki Uchidae ; Heiwa Kanamorif ; Takahiro Fukudag ; Koichi Miyamurah ; Yoshiko Inouei ; Jun Taguchij ; Takehiko Morik ; Koji Iwatol ; Yasuo Morishimam ; Tokiko Nagamura-Inouen ; Yoshiko Atsutao ; p ; Hisashi Sakamakid ; Akiyoshi Takamiq
- 关键词：Acute erythroid leukemia ; Acute megakaryoblastic leukemia ; Allogeneic hematopoietic stem cell transplantation
- 刊名：Leukemia Research
- 出版年：2016
- 出版时间：August 2016
- 年：2016
- 卷：47
- 期：Complete
- 页码：47-53
- 全文大小：867 K
文摘
- •
M6 and M7 of acute myeloid leukemia are considered to be closely related in origin.
- •
We conducted a nationwide survey on outcomes of allo-HSCT in patients with M6 or M7.
- •
The overall survival of M6 patients was significantly better than that of M7.
- •
Unknown mechanisms influence the HSCT outcomes of these closely related subtypes.